Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Fr | BioSig Technologies Inc reports results for the quarter ended September 30 - Earnings Summary | 1 | Reuters | ||
BIOSIG TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
14.11. | BioSig Technologies, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
13.11. | BioSig Technologies, Inc.: BioSig Regains Compliance with Nasdaq's Minimum Bid Price Requirement | 4 | GlobeNewswire (Europe) | Los Angeles, CA, Nov. 13, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or "Company"), a medical technology company delivering unprecedented accuracy and precision to... ► Artikel lesen | |
13.11. | BioSig Technologies, Inc. - 8-K, Current Report | - | SEC Filings | ||
09.11. | BioSig Technologies Inc expected to post a loss of 20 cents a share - Earnings Preview | 2 | Reuters | ||
29.10. | BioSig Faces NASDAQ Delisting Over Price Deficiency | 1 | Investing.com | ||
29.10. | BioSig droht Delisting von der NASDAQ aufgrund zu niedriger Aktienkurse | 1 | Investing.com Deutsch | ||
29.10. | BioSig Technologies, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
22.10. | BioSig Technologies, Inc.: BioSig Technologies' Common Stock to Resume Trading on the NASDAQ Exchange, Wednesday, October 23, 2024 After Its Successful Appeal to the NASDAQ Panel | 46 | GlobeNewswire (Europe) | Los Angeles, CA, Oct. 22, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM) ("BioSig" or the "Company"), a medical technology company delivering unprecedented accuracy and precision... ► Artikel lesen | |
22.10. | BioSig granted grace period to meet Nasdaq listing requirements | 1 | Investing.com | ||
22.10. | BioSig erhält Gnadenfrist zur Erfüllung der Nasdaq-Notierungsanforderungen | 1 | Investing.com Deutsch | ||
22.10. | BioSig Technologies, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
13.09. | BioSig ernennt neuen Vorstandsvorsitzenden und passt Vergütungsstruktur an | 2 | Investing.com Deutsch | ||
13.09. | BioSig Technologies, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
14.08. | BioSig Technologies, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
31.07. | BioSig Technologies, Inc.: BioSig Technologies Announces Intent to Acquire the Assets of Neuro-Kinesis Corporation | 113 | GlobeNewswire (Europe) | Los Angeles, July 31, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM) ("BioSig" or "Company"), a medical technology company delivering unprecedented accuracy and precision to intra-cardiac... ► Artikel lesen | |
25.07. | BioSig Technologies, Inc.: BioSig Technologies Improves Balance Sheet, Announces Reduction in Outstanding Payables during Q2 2024 | 62 | GlobeNewswire (Europe) | Los Angeles, CA 90025, July 25, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM) or ("BioSig" or "Company"), a medical technology company delivering unprecedented accuracy and precision... ► Artikel lesen | |
24.07. | BioSig Technologies, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
24.07. | BioSig Technologies, Inc. - S-1/A, General form for registration of securities | - | SEC Filings | ||
27.06. | BioSig Technologies, Inc. - S-1, General form for registration of securities | 1 | SEC Filings |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
EMEIS | 5,705 | +1,44 % | emeis: Upturn in Performance Confirmed in Third-Quarter 2024 | Revenue up +8.3%, occupancy rate up +2.6 points
Regulatory News:
emeis (Paris:EMEIS):
Growth in all core activities and in all geographical areas (revenue and occupancy rate)
Solid... ► Artikel lesen | |
NANO-X IMAGING | 5,890 | 0,00 % | Nano-X Imaging LTD.: Nanox Receives FDA Clearance for HealthCCSng V2.0, Upgraded Version of Advanced AI Cardiac Solution Empowering Physicians in Assessment of Coronary Artery Calcium | HealthCCSng V2.0 introduces additional 'zero calcium' categorization of coronary artery calcium (CAC) and generates a numerical calcium score with corresponding CAC detection category output Marks... ► Artikel lesen | |
CAREDX | 21,520 | +1,32 % | CareDx Reports Preliminary Financial Results for Third Quarter 2024 | BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) - The Transplant Company - a leading precision medicine company focused on the discovery, development, and commercialization of clinically... ► Artikel lesen | |
BUTTERFLY NETWORK | 3,325 | 0,00 % | BFLY-Aktie erreicht 52-Wochen-Hoch bei 2,95 US-Dollar | ||
GOODRX | 4,310 | 0,00 % | GoodRx Holdings one of the most undervalued stocks, Leerink says | ||
TALKSPACE | 3,160 | 0,00 % | Espresa Partners with Talkspace to Boost Employee Well-Being with Accessible Mental Health Benefits | Espresa has partnered with Talkspace to expand mental health support for employees. Through Espresa's platform, clients now have access to Talkspace's 5,000+ licensed therapists, offering secure, on-demand... ► Artikel lesen | |
CARMAT | 1,190 | -1,00 % | CARMAT's Aeson Artificial Heart Is Gradually Becoming a Reference Solution for Bridge to Transplant in Europe | Milestone of 30 heart transplants post Aeson® support, passed Strong interest in Aeson® from the medical community: more than 100 European experts will share their experience at the first... ► Artikel lesen | |
JOINT CORP | 11,310 | 0,00 % | JYNT's Q3 Earnings Meet Estimates Amid Higher Costs, Shares Dip 3% | ||
MIMEDX | 9,070 | 0,00 % | MIMEDX GROUP, INC. - 8-K, Current Report | ||
HYPERFINE | 0,900 | 0,00 % | Hyperfine, Inc. Reports Third Quarter 2024 Financial Results | GUILFORD, Connecticut, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 92,70 | 0,00 % | Looking Into PROCEPT BioRobotics' Recent Short Interest | ||
BIOMERICA | 0,320 | 0,00 % | Biomerica, Inc.: Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements | IRVINE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a leading global provider of advanced medical diagnostics, announced that it has been granted an additional 180-day... ► Artikel lesen | |
PROGYNY | 13,980 | 0,00 % | Barclays Lowers Progyny (NASDAQ:PGNY) Price Target to $17.00 | ||
ATRICURE | 36,030 | 0,00 % | Pre-market Movers: ASP Isotopes, NerdWallet, Reddit, AtriCure, Qorvo | OLATHE (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green ASP Isotopes Inc. (ASPI) is up over 44% at $8.33.
NerdWallet... ► Artikel lesen | |
LIFEMD | 5,400 | 0,00 % | LifeMD, Inc.: LifeMD Reports Third Quarter 2024 Results | Total revenues increased 38% year-over-year to $53.4 million with telehealth revenue up 65%Record gross margin of 90.6%, up 300 basis points from the year-ago periodAdjusted EBITDA increased 33% to... ► Artikel lesen |